v3.25.0.1
Other Non-Financial Assets
 12 Months Ended
Dec. 31, 2024
Other Non-Financial Assets [Abstract]  
Other Non-Financial Assets Other Non-Financial Assets
(in millions €)
December 31, 2024
December 31, 2023
Deferred expenses
166.8
284.9
Prepayments related to service contracts
27.7
28.3
Other
44.5
51.1
Total
239.0
364.3
Total current
212.7
280.9
Total non-current
26.3
83.4
Deferred expenses mainly comprise prepayments for future expenses of €83.1 million (€151.1 million as of
December 31, 2023) for the settlement fee of the European Commission to our collaboration partner and
prepayments for our collaborations with Ryvu Therapeutics S.A., Krakow, Poland, €8.5 million (€15.7 million as
of December 31, 2023) and MediLink Therapeutics Co., Ltd, Suzhou, China, €17.7 million (nil as of
December 31, 2023). The remaining deferred expenses mainly comprise insurance obligations of €18.2 million
and service contracts.